ProfileGDS4718 / 213764_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 48% 93% 26% 66% 4% 9% 32% 79% 61% 41% 42% 3% 1% 8% 51% 74% 22% 2% 20% 60% 76% 33% 81% 40% 10% 69% 14% 59% 10% 1% 30% 69% 8% 55% 28% 4% 72% 9% 88% 32% 3% 59% 12% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8120436
GSM549102patient 115, normal, homogenized [OPG study]5.4013448
GSM549104patient 119, normal, homogenized [OPG study]9.7603293
GSM549108patient 138, normal, homogenized [OPG study]4.4285626
GSM549119patient 077, normal, homogenized [OPG study]6.5099566
GSM549133patient 032, cancer, homogenized [OPG study]3.530694
GSM549139patient 042, cancer, homogenized [OPG study]3.717319
GSM549099patient 107, normal, homogenized [OPG study]4.650932
GSM549109patient 139, normal, homogenized [OPG study]7.7300379
GSM549110patient 046, normal, homogenized [OPG study]6.1814961
GSM549114patient 063, normal, homogenized [OPG study]4.9861941
GSM549122patient 082, normal, homogenized [OPG study]5.0808842
GSM549134patient 033, cancer, homogenized [OPG study]3.507723
GSM549136patient 036, cancer, homogenized [OPG study]3.341711
GSM549140patient 044, cancer, homogenized [OPG study]3.66838
GSM549111patient 047, normal, homogenized [OPG study]5.5464151
GSM549113patient 057, normal, homogenized [OPG study]7.2748174
GSM549132patient 031, cancer, homogenized [OPG study]4.1910422
GSM549137patient 038, cancer, homogenized [OPG study]3.423362
GSM549142patient 047, cancer, homogenized [OPG study]4.2307820
GSM549100patient 110, normal, homogenized [OPG study]6.0950860
GSM549107patient 135, normal, homogenized [OPG study]7.4867176
GSM549115patient 068, normal, homogenized [OPG study]4.6201833
GSM549116patient 072, normal, homogenized [OPG study]8.0246881
GSM549120patient 078, normal, homogenized [OPG study]4.9652140
GSM549131patient 030, cancer, homogenized [OPG study]3.757310
GSM549118patient 074, normal, homogenized [OPG study]6.7969569
GSM549129patient 027, cancer, homogenized [OPG study]3.9346914
GSM549123patient 088, normal, homogenized [OPG study]6.0452959
GSM549124patient 006, cancer, homogenized [OPG study]3.8184210
GSM549126patient 015, cancer, homogenized [OPG study]3.243911
GSM549128patient 025, cancer, homogenized [OPG study]4.5335630
GSM549103patient 117, normal, homogenized [OPG study]6.7444869
GSM549117patient 073, normal, homogenized [OPG study]3.697228
GSM549138patient 041, cancer, homogenized [OPG study]5.8177855
GSM549141patient 045, cancer, homogenized [OPG study]4.3799228
GSM549130patient 028, cancer, homogenized [OPG study]3.529074
GSM549101patient 111, normal, homogenized [OPG study]7.0630672
GSM549105patient 128, normal, homogenized [OPG study]3.745889
GSM549106patient 134, normal, homogenized [OPG study]9.0263588
GSM549112patient 048, normal, homogenized [OPG study]4.5980232
GSM549125patient 011, cancer, homogenized [OPG study]3.493133
GSM549127patient 024, cancer, homogenized [OPG study]6.1084559
GSM549135patient 035, cancer, homogenized [OPG study]3.803112